These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 24755374)

  • 1. Inhibitors of the peptidoglycan biosynthesis enzymes MurA-F.
    Hrast M; Sosič I; Sink R; Gobec S
    Bioorg Chem; 2014 Aug; 55():2-15. PubMed ID: 24755374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Advances in the research of inhibitors of enzymes of bacterial peptidoglycan biosynthesis].
    Liu F; Meng HY; Sun ZY; Li DY; Jin YY; Yang ZY; Wu SJ; Chen J
    Yao Xue Xue Bao; 2017 Mar; 52(3):362-70. PubMed ID: 29979555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure and function of the Mur enzymes: development of novel inhibitors.
    El Zoeiby A; Sanschagrin F; Levesque RC
    Mol Microbiol; 2003 Jan; 47(1):1-12. PubMed ID: 12492849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The early stage peptidoglycan biosynthesis Mur enzymes are antibacterial and antisporulation drug targets for recurrent Clostridioides difficile infection.
    Sapkota M; Marreddy RKR; Wu X; Kumar M; Hurdle JG
    Anaerobe; 2020 Feb; 61():102129. PubMed ID: 31760080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of novel inhibitors targeting intracellular steps of peptidoglycan biosynthesis.
    Kotnik M; Anderluh PS; Prezelj A
    Curr Pharm Des; 2007; 13(22):2283-309. PubMed ID: 17692001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benzothioxalone derivatives as novel inhibitors of UDP-N-acetylglucosamine enolpyruvyl transferases (MurA and MurZ).
    Miller K; Dunsmore CJ; Leeds JA; Patching SG; Sachdeva M; Blake KL; Stubbings WJ; Simmons KJ; Henderson PJ; De Los Angeles J; Fishwick CW; Chopra I
    J Antimicrob Chemother; 2010 Dec; 65(12):2566-73. PubMed ID: 20861142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. UDP-N-acetylglucosamine enolpyruvyl transferase as a potential target for antibacterial chemotherapy: recent developments.
    Gautam A; Rishi P; Tewari R
    Appl Microbiol Biotechnol; 2011 Oct; 92(2):211-25. PubMed ID: 21822642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The nature of Staphylococcus aureus MurA and MurZ and approaches for detection of peptidoglycan biosynthesis inhibitors.
    Blake KL; O'Neill AJ; Mengin-Lecreulx D; Henderson PJ; Bostock JM; Dunsmore CJ; Simmons KJ; Fishwick CW; Leeds JA; Chopra I
    Mol Microbiol; 2009 Apr; 72(2):335-43. PubMed ID: 19298367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Avenaciolides: potential MurA-targeted inhibitors against peptidoglycan biosynthesis in methicillin-resistant Staphylococcus aureus (MRSA).
    Chang CM; Chern J; Chen MY; Huang KF; Chen CH; Yang YL; Wu SH
    J Am Chem Soc; 2015 Jan; 137(1):267-75. PubMed ID: 25521652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feglymycin is an inhibitor of the enzymes MurA and MurC of the peptidoglycan biosynthesis pathway.
    Rausch S; Hänchen A; Denisiuk A; Löhken M; Schneider T; Süssmuth RD
    Chembiochem; 2011 May; 12(8):1171-3. PubMed ID: 21538763
    [No Abstract]   [Full Text] [Related]  

  • 11. Mur Ligase Inhibitors as Anti-bacterials: A Comprehensive Review.
    Sangshetti JN; Joshi SS; Patil RH; Moloney MG; Shinde DB
    Curr Pharm Des; 2017; 23(21):3164-3196. PubMed ID: 28201974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sesquiterpene lactones are potent and irreversible inhibitors of the antibacterial target enzyme MurA.
    Bachelier A; Mayer R; Klein CD
    Bioorg Med Chem Lett; 2006 Nov; 16(21):5605-9. PubMed ID: 16945528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a one-pot assay for screening and identification of Mur pathway inhibitors in Mycobacterium tuberculosis.
    Eniyan K; Kumar A; Rayasam GV; Perdih A; Bajpai U
    Sci Rep; 2016 Oct; 6():35134. PubMed ID: 27734910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationships of tulipalines, tuliposides, and related compounds as inhibitors of MurA.
    Mendgen T; Scholz T; Klein CD
    Bioorg Med Chem Lett; 2010 Oct; 20(19):5757-62. PubMed ID: 20729083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of new MurA inhibitors using induced-fit simulation and docking.
    Rožman K; Lešnik S; Brus B; Hrast M; Sova M; Patin D; Barreteau H; Konc J; Janežič D; Gobec S
    Bioorg Med Chem Lett; 2017 Feb; 27(4):944-949. PubMed ID: 28077258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Potential of Mur Enzymes as Targets for Antimicrobial Drug Discovery.
    Kumar D; Sarkar N; Roy KK; Bisht D; Kumar D; Mandal B; Rajagopal M; Dey YN
    Curr Drug Targets; 2023; 24(8):627-647. PubMed ID: 37291783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of druggable targets for Acinetobacter baumannii via subtractive genomics and plausible inhibitors for MurA and MurB.
    Kaur N; Khokhar M; Jain V; Bharatam PV; Sandhir R; Tewari R
    Appl Biochem Biotechnol; 2013 Sep; 171(2):417-36. PubMed ID: 23846799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MurA as a primary target of tulipalin B and 6-tuliposide B.
    Shigetomi K; Olesen SH; Yang Y; Mitsuhashi S; Schönbrunn E; Ubukata M
    Biosci Biotechnol Biochem; 2013; 77(12):2517-9. PubMed ID: 24317075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reaching toward underexplored targets in antibacterial drug design.
    Jukič M; Gobec S; Sova M
    Drug Dev Res; 2019 Feb; 80(1):6-10. PubMed ID: 30312991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elucidating the inhibition of peptidoglycan biosynthesis in Staphylococcus aureus by albocycline, a macrolactone isolated from Streptomyces maizeus.
    Liang H; Zhou G; Ge Y; D'Ambrosio EA; Eidem TM; Blanchard C; Shehatou C; Chatare VK; Dunman PM; Valentine AM; Voelz VA; Grimes CL; Andrade RB
    Bioorg Med Chem; 2018 Jul; 26(12):3453-3460. PubMed ID: 29805074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.